共 50 条
A mesenchymal chondrosarcoma with aberrant nuclear expression of STAT6: a potential diagnostic pitfall
被引:4
|作者:
Broggi, Giuseppe
[1
]
Mazzucchelli, Manuel
[1
]
Covello, Renato
[2
]
Casini, Beatrice
[2
]
Broggi, Giuseppe Maria Vincenzo
[3
,4
]
Salvatorelli, Lucia
[1
]
Magro, Gaetano
[1
]
机构:
[1] Univ Catania, Dept Med Surg Sci & Adv Technol GF Ingrassia, Anat Pathol, I-95123 Catania, Italy
[2] Regina Elena Natl Canc Inst IRCCS, Pathol Dept, I-00168 Rome, Italy
[3] Univ Catania, Dept Med Surg Sci & Adv Technol GF Ingrassia, Neurol Surg, Policlin Rodolico San Marco Univ Hosp, I-95123 Catania, Italy
[4] Univ Catania, Interdisciplinary Res Ctr Diag & Therapy Brain Tu, I-95123 Catania, Italy
关键词:
Mesenchymal chondrosarcoma;
STAT6;
HEY1-NCOA2 fusion gene;
NAB2-STAT6 fusion gene;
Diagnostic pitfall;
SOLITARY FIBROUS TUMOR;
IMMUNOHISTOCHEMISTRY;
FUSION;
D O I:
10.1016/j.prp.2022.153803
中图分类号:
R36 [病理学];
学科分类号:
100104 ;
摘要:
STAT6 is usually considered to be a very sensitive and specific immunomarker for diagnosis of solitary fibrous tumor (SFT), being a surrogate of the NAB2-STAT6 fusion gene identified in most cases of this tumor. STAT6 expression has also been reported in rare cases of other soft tissue tumors, such as low-grade fibromyxoid sar -coma, myxoid/round cell liposarcoma, dedifferentiated liposarcoma and deep fibrous histiocytoma. The aim of this study was to report, for the first time, a case of mesenchymal chondrosarcoma showing diffuse aberrant immunohistochemical expression of STAT6. Molecular biology, showing the HEY1-NCOA2 fusion gene, was crucial to rule out SFT.
引用
收藏
页数:4
相关论文